ArticleCell death & disease2024

Treating ICB-resistant cancer by inhibiting PD-L1 via DHHC3 degradation induced by cell penetrating peptide-induced chimera conjugates.

Yu-Ying Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.